Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 103 citing articles:

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Nur Samsu
BioMed Research International (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 603
Mechanisms of podocyte injury and implications for diabetic nephropathy
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 115
The cardio-renal-metabolic connection: a review of the evidence
Marella Marassi, Gian Paolo Fadini
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Na Wang, Chun Zhang
Antioxidants (2024) Vol. 13, Iss. 4, pp. 455-455
Open Access | Times Cited: 39
Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management
Natesan Vijayakumar, Sungjin Kim
Biomolecules & Therapeutics (2021) Vol. 29, Iss. 4, pp. 365-372
Open Access | Times Cited: 90
SIRT1-FOXOs activity regulates diabetic complications
Manjiri P. Jalgaonkar, Urvi M. Parmar, Yogesh A. Kulkarni, et al.
Pharmacological Research (2021) Vol. 175, pp. 106014-106014
Closed Access | Times Cited: 76
The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders
Stefano Menini, Carla Iacobini, Martina Vitale, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1812-1812
Open Access | Times Cited: 72
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
Annalisa Giandalia, Alfio Edoardo Giuffrida, Guido Gembillo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5808-5808
Open Access | Times Cited: 67
The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management
Mahendra Kumar, Shah Dev, Muhammad Khalid, et al.
Cureus (2023)
Open Access | Times Cited: 34
Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease
Yue-Ming Gao, Weijia Chen, Zhenling Deng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 23
Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease
Jakob Appel Østergaard, Mark E. Cooper, Karin Jandeleit‐Dahm
Journal of Nephrology (2020) Vol. 33, Iss. 5, pp. 917-929
Closed Access | Times Cited: 58
Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort
Emily de Souza Ferreira, Tiago Ricardo Moreira, Rodrigo Gomes da Silva, et al.
BMC Nephrology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing
Elena A. Christofides, Niraj Desai
Journal of Primary Care & Community Health (2021) Vol. 12
Open Access | Times Cited: 46
Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
Tadesse Asmamaw Dejenie, Endeshaw Chekol Abebe, Misganaw Asmamaw Mengstie, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 21
Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
Su Jin Jeong, Seung Eun Lee, Dong Hyun Shin, et al.
BMC Nephrology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 38
Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives
Domenico Santoro, Massimo Torreggiani, Vincenzo Pellicanò, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5425-5425
Open Access | Times Cited: 36
Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes
Biff F. Palmer
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1434-1443
Open Access | Times Cited: 14
Ferroptosis in diabetic nephropathy: Mechanisms and therapeutic implications
Misganaw Asmamaw Mengstie, Mohammed Abdu Seid, Natnael Atnafu Gebeyehu, et al.
Metabolism Open (2023) Vol. 18, pp. 100243-100243
Open Access | Times Cited: 13
Diagnostic value of serum TGF-β1 and CysC in type 2 diabetic kidney disease: a cross-sectional study
Yi Kang, Jin Qian, Mengqi Zhou, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Impairment of platelet mitochondrial respiration in patients with chronic kidney disease with and without diabetes
Glăvan Mihaela-Roxana, Stanciu-Lelcu Theia, Aburel Oana-Maria, et al.
Molecular and Cellular Biochemistry (2025)
Open Access
The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies
Michela Amatruda, Guido Gembillo, Alfio Edoardo Giuffrida, et al.
Medicina (2021) Vol. 57, Iss. 9, pp. 868-868
Open Access | Times Cited: 30
Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
Ya Yue, Jui‐Ning Yeh, John Y. Chiang, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Exercise in the Prevention and Treatment of Type 2 Diabetes
John P. Kirwan, Elizabeth C. Heintz, Candida J. Rebello, et al.
Comprehensive physiology (2023), pp. 4559-4585
Closed Access | Times Cited: 11
YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway
Xin Li, Tian‐Kui Ma, Min Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
The unique association between the level of plateletcrit and the prevalence of diabetic kidney disease: a cross-sectional study
Shuwu Wei, Xinyu Pan, Yao Xiao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top